norstella-logo-white
Contact us

Refine results

refine

Resources

Toggle Filters
Podcast icon
Podcast

Conference catch-up: The rise of...

October 3, 2024
Healthcare technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In particular, digital therapeutics have become a prominent area of focus due to their potential to improve outcomes...
Listen to the podcast
Video icon
Video

Redefining patient access strategy

September 18, 2024
Patient access continues to be a major hurdle in the US pharma industry, impacting the speed of drug development and therefore the delivery of life-saving treatments to patients. To assess the current state of patient access,...
Watch the video
ebook icon
ebook

The next wave in oncology:...

September 12, 2024
Oncology is undergoing a transformative shift, with new therapies and technologies driving significant improvements in cancer care. The Next Wave in Oncology explores seven groundbreaking advancements, from antibody-drug conjugates (ADCs) to artificial intelligence, that are redefining...
Access the ebook
Article icon
Article

Pharma outlook: From uncertainty to...

September 9, 2024
Change is the only constant in the pharmaceuticals industry. There have been many paradigm shifts driven by specific therapies, like AIDS in the 1990s and the COVID-19 vaccine in 2020, and some believe that the recent...
Read the article
Article icon
Article

The evolution of cell therapy...

August 7, 2024
Cell and gene therapies (C&GTs) enjoyed “a landmark close” to 2023 and continued its momentum in Q1 2024 with “several notable approvals and strong growth in all stages of clinical development”, according to the latest quarterly...
Read the article
ebook icon
ebook

How Norstella is embedding artificial...

July 8, 2024
In this white paper, Norstella describes its vision for the integration of artificial intelligence with its industry-leading data and advisory services. At each step from pipeline to patient, Norstella is embedding AI to create the next...
Access the ebook
Report icon
Report

Putting the patient first: Advancing...

June 17, 2024
Norstella is driven by its mission: Helping patients gain access to life-saving therapies by transforming the drug development journey. Norstella is working to fulfill this mission in a challenging landscape for pharmaceutical, medtech, and clinical research...
Access the report
Infographic icon
Infographic

Obesity R&D in 2024 &...

June 5, 2024
Norstella empowers stakeholders involved in obesity drug development to make informed decisions based on trusted industry data and expert insights. This infographic uses some of those data and insights to demonstrate the various complex factors that...
Access the infographic
category
Podcast

Conference catch-up: The rise of... Conference catch-up: The rise of digital therapeutics

October 3, 2024
Healthcare technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving...
View resource
category
Article

Pharma’s future: More with less Pharma’s future: More with less

October 1, 2024
2023 saw the biopharmaceutical industry spend a record $300bn on R&D activities, reinvesting approximately 30%...
View resource
category
Video

Redefining patient access strategy Redefining patient access strategy

September 18, 2024
Patient access continues to be a major hurdle in the US pharma industry, impacting the...
View resource
category
ebook

The next wave in oncology:... The next wave in oncology: 7 innovations redefining cancer treatment in 2024 and beyond

September 12, 2024
Oncology is undergoing a transformative shift, with new therapies and technologies driving significant improvements in...
View resource
category
Article

Pharma outlook: From uncertainty to... Pharma outlook: From uncertainty to predictability

September 9, 2024
Change is the only constant in the pharmaceuticals industry. There have been many paradigm shifts...
View resource
category
Article

The evolution of cell therapy... The evolution of cell therapy to address unmet medical needs

August 7, 2024
Cell and gene therapies (C&GTs) enjoyed “a landmark close” to 2023 and continued its momentum...
View resource
category
Article

2024 FDA diversity guidance: What... 2024 FDA diversity guidance: What it means and how it could impact future clinical trial outcomes

July 30, 2024
The US Food and Drug Administration (FDA) released a diversity-focused draft guidance entitled “Diversity Action...
View resource
category
ebook

How Norstella is embedding artificial... How Norstella is embedding artificial intelligence to improve pipeline to patient decision-making

July 8, 2024
In this white paper, Norstella describes its vision for the integration of artificial intelligence with...
View resource
category
Article

How can small biopharma use... How can small biopharma use end-to-end CDMO partnerships to accelerate development?

July 3, 2024
There is growing evidence that pharma and biotech companies in general, and small biopharmas in...
View resource
category
Video

Class of 2024: Norstella intern... Class of 2024: Norstella intern yearbook

June 27, 2024
As members of a vastly expanding industry, it is our job to empower other problem-solvers...
View resource
category
Report

Putting the patient first: Advancing... Putting the patient first: Advancing biopharma innovation and industry transformation

June 17, 2024
Norstella is driven by its mission: Helping patients gain access to life-saving therapies by transforming...
View resource
category
Infographic

Obesity R&D in 2024 &... Obesity R&D in 2024 & beyond: Key considerations in an increasingly competitive landscape

June 5, 2024
Norstella empowers stakeholders involved in obesity drug development to make informed decisions based on trusted...
View resource